← Eichor
Study identifier: NCT05922969 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

Safety of Low PEEP Maneuvers During ARDS Management

Condition: Acute Respiratory Distress Syndrome · Positive End Expiratory Pressure  ·  Sponsor: Centre Hospitalier Universitaire, Amiens

PhaseN/A
Planned participants50
Who can joinAll sexes, 18 Years to no upper limit
Healthy volunteersNo

About this study

Acute Respiratory distress syndrome (ARDS) is a severe condition in which protective ventilation is a critical point in its management. Positive end expiratory pressure (PEEP) setting can be challenging for clinicians and high PEEP has been associated with better outcome in moderate and severe ARDS. Recently, recruitment to inflation ratio and airway closure have been investigated in order to help PEEP adjustment. However, ventilatory maneuvers are performed with a low level of PEEP and therefore expose to derecruitment and oxygen desaturation. So far, the risk of oxygen desaturation has not been investigated and risk factors are unknown. The aim of this study is to evaluate the prevalence of oxygen desaturation during ventilatory maneuvers at low level of PEEP in patients with moderate or severe ARDS

This description comes directly from the study's public registry record.

Talk to the study team

Yoann Zerbib, MD  ·  03 22 08 77 23  ·  Zerbib.yoann@chu-amiens.fr

Always discuss trial participation with your own doctor first.

Locations (1)

CHU AmiensAmiens, FranceRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT05922969